Responses
Abstracts Accepted for Publication
Psoriatic arthritis
AB0785 Consistent safety profile with up to 4 years of apremilast treatment: analysis of data from 1493 patients with psoriatic arthritis in 3 large, phase iii, long-term studies
Compose a Response to This Article
Other responses
No responses have been published for this article.